Non-Alcoholic Fatty Liver Disease in HIV Infection.
Non-alcoholic fatty liver disease is one of the most frequent chronic hepatic conditions worldwide. The spectrum of non-alcoholic fatty liver disease goes from hepatic steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Risk factors for non-alcoholic fatty liver disease are metabo...
| Publicado en: | AIDS Reviews Vol. 19; no. 1; pp. 35 - 47 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Publicidad Permanyer SLU
Jan-Mar2017
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=121272748&site=ehost-live header: @attributes: shortDbName: lth uiTerm: 121272748 longDbName: MedicLatina uiTag: AN controlInfo: bkinfo: jinfo: jid: 11396121 3PWJ jtl: AIDS Reviews issn: 11396121 maglogo: N pubinfo: dt: Jan-Mar2017 vid: 19 iid: 1 pid: 37650 pub: Publicidad Permanyer SLU artinfo: ui: 121272748 ppf: 35 ppct: 12 formats: fmt: @attributes: type: P size: 7.3MB tig: atl: Non-Alcoholic Fatty Liver Disease in HIV Infection. aug: au: Macías, Juan Pineda, Juan A. Real, Luis M. affil: Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain. su: Liver diseases HIV infections Highly active antiretroviral therapy Fatty liver Therapeutics Cirrhosis of the liver sug: subj: Liver diseases HIV infections Highly active antiretroviral therapy Fatty liver Therapeutics Cirrhosis of the liver keyword: Antiretroviral therapy HCV infection HIV infection NAFLD Steatohepatitis ab: Non-alcoholic fatty liver disease is one of the most frequent chronic hepatic conditions worldwide. The spectrum of non-alcoholic fatty liver disease goes from hepatic steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Risk factors for non-alcoholic fatty liver disease are metabolic, mainly obesity and the accompanying consequences. Treatment and prevention of non-alcoholic fatty liver disease should target those metabolic abnormalities. The frequency of and the factors associated with hepatic steatosis in HIV infection seem to be similar to those reported in the general population, though direct comparisons are lacking. Hepatic steatosis in HIV infection may also be secondary to antiretroviral drugs or HCV-related factors in HCV-coinfected subjects. However, more recent data suggest that hepatic steatosis in HIV infection represents true non-alcoholic fatty liver disease. As such, management of non-alcoholic fatty liver disease in HIV infection should follow the same principles as in the general population. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Copyright of AIDS Reviews is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: AIDS Reviews holder: Publicidad Permanyer SLU dt: @attributes: year: 2017 holdings: @attributes: islocal: N |
|---|